Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for th

Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S.PALO ALTO, Calif.--(BUSINESS WIRE)--Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the U.S....

Related Keywords

Tokyo ,Japan ,United States ,American ,Noriko Tojo ,Lara Barghout ,Naomi Fisher ,Harvard Medical School ,Journal Of The American Medical Association ,Division Of Endocrinology ,Otsuka Holdings Co Ltd ,Tokyo Stock Exchange ,Recor Medical Inc ,Drug Administration ,Hypertension Service ,Otsuka Medical Devices Co Ltd ,Renal Denervation ,Recor Medical ,Ultrasound Renal Denervation ,Committee Panel ,Clinical Trial ,American Medical Association ,Paradise Ultrasound ,Paradise Ultrasound Renal Denervation ,Associate Professor ,Hypertension Innovation ,Representative Director ,Otsuka Medical Devices ,Executive Director ,Palo Alto ,Paradise System ,Global Paradise System ,Medical Devices ,